ID

33712

Descripción

Incretin-based Drugs and Acute Pancreatitis; ODM derived from: https://clinicaltrials.gov/show/NCT02476760

Link

https://clinicaltrials.gov/show/NCT02476760

Palabras clave

Versiones (1)
  1. 20/12/18 20/12/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

20 de diciembre de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Diabetes Mellitus, Type 2 NCT02476760

Inglés

Eligibility Diabetes Mellitus, Type 2 NCT02476760

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients with a first-ever prescription for a non-insulin anti-diabetic drug, including biguanides, sulfonylureas, thiazolidinediones, dpp-4 inhibitors, glp-1 analogs, alpha-glucosidase inhibitors, meglitinides or combinations of these drugs from the earliest availability of data at each site to the last date of availability of data.
Descripción

Antidiabetics Except Insulin | Biguanides | Sulfonylureas | Thiazolidinediones | DPP-4 Inhibitor | GLP-1 Analogue | alpha-Glucosidase Inhibitors | Meglitinide | Combined Modality Therapy

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0935929
UMLS CUI [1,2]
C0332300
UMLS CUI [1,3]
C0021641
UMLS CUI [2]
C0005382
UMLS CUI [3]
C0038766
UMLS CUI [4]
C1257987
UMLS CUI [5]
C3537225
UMLS CUI [6]
C3273809
UMLS CUI [7]
C1299007
UMLS CUI [8]
C0065880
UMLS CUI [9]
C0009429
patients with at least 1 year of history in the database.
Descripción

Medical History Database Duration

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0242356
UMLS CUI [1,3]
C0449238
patients at least 18 years of age.
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients who died or left the cohort before the year the first incretin-based drug entered the market.
Descripción

Patient Outcome - Died | Cohort Withdrawal by Subject

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1546956
UMLS CUI [2,1]
C0599755
UMLS CUI [2,2]
C1710677
patients who never added-on or switched to a new anti-diabetic drug after incretin-based drugs entered the market up until june 30, 2014.
Descripción

Absence Antidiabetics Additional | Absence Antidiabetics Change

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0332197
UMLS CUI [1,2]
C0935929
UMLS CUI [1,3]
C1524062
UMLS CUI [2,1]
C0332197
UMLS CUI [2,2]
C0935929
UMLS CUI [2,3]
C0392747
patients with a previous diagnosis of pancreatic cancer, those who underwent pancreatectomy, those with diagnoses of congenital defects of the pancreas, cystic fibrosis, lupus, or previous bariatric surgery, at any time prior to study cohort entry.
Descripción

Pancreatic carcinoma | Pancreatectomy | Congenital defects Pancreas | Cystic Fibrosis | Lupus Erythematosus | Bariatric Surgery

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0235974
UMLS CUI [2]
C0030279
UMLS CUI [3,1]
C0000768
UMLS CUI [3,2]
C0030274
UMLS CUI [4]
C0010674
UMLS CUI [5]
C0409974
UMLS CUI [6]
C1456587
patients diagnosed with hiv or initiating haart therapy before and at study cohort entry.
Descripción

HIV Infection | HAART

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019693
UMLS CUI [2]
C0887947
patients hospitalized for acute pancreatitis in the 30 days before study cohort entry.
Descripción

Hospitalization Pancreatitis

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0030305
Volver a la parte superior de la página

Similar models

Eligibility Diabetes Mellitus, Type 2 NCT02476760

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Antidiabetics Except Insulin | Biguanides | Sulfonylureas | Thiazolidinediones | DPP-4 Inhibitor | GLP-1 Analogue | alpha-Glucosidase Inhibitors | Meglitinide | Combined Modality Therapy
Item
patients with a first-ever prescription for a non-insulin anti-diabetic drug, including biguanides, sulfonylureas, thiazolidinediones, dpp-4 inhibitors, glp-1 analogs, alpha-glucosidase inhibitors, meglitinides or combinations of these drugs from the earliest availability of data at each site to the last date of availability of data.
boolean
C0935929 (UMLS CUI [1,1])
C0332300 (UMLS CUI [1,2])
C0021641 (UMLS CUI [1,3])
C0005382 (UMLS CUI [2])
C0038766 (UMLS CUI [3])
C1257987 (UMLS CUI [4])
C3537225 (UMLS CUI [5])
C3273809 (UMLS CUI [6])
C1299007 (UMLS CUI [7])
C0065880 (UMLS CUI [8])
C0009429 (UMLS CUI [9])
Medical History Database Duration
Item
patients with at least 1 year of history in the database.
boolean
C0262926 (UMLS CUI [1,1])
C0242356 (UMLS CUI [1,2])
C0449238 (UMLS CUI [1,3])
Age
Item
patients at least 18 years of age.
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Patient Outcome - Died | Cohort Withdrawal by Subject
Item
patients who died or left the cohort before the year the first incretin-based drug entered the market.
boolean
C1546956 (UMLS CUI [1])
C0599755 (UMLS CUI [2,1])
C1710677 (UMLS CUI [2,2])
Absence Antidiabetics Additional | Absence Antidiabetics Change
Item
patients who never added-on or switched to a new anti-diabetic drug after incretin-based drugs entered the market up until june 30, 2014.
boolean
C0332197 (UMLS CUI [1,1])
C0935929 (UMLS CUI [1,2])
C1524062 (UMLS CUI [1,3])
C0332197 (UMLS CUI [2,1])
C0935929 (UMLS CUI [2,2])
C0392747 (UMLS CUI [2,3])
Pancreatic carcinoma | Pancreatectomy | Congenital defects Pancreas | Cystic Fibrosis | Lupus Erythematosus | Bariatric Surgery
Item
patients with a previous diagnosis of pancreatic cancer, those who underwent pancreatectomy, those with diagnoses of congenital defects of the pancreas, cystic fibrosis, lupus, or previous bariatric surgery, at any time prior to study cohort entry.
boolean
C0235974 (UMLS CUI [1])
C0030279 (UMLS CUI [2])
C0000768 (UMLS CUI [3,1])
C0030274 (UMLS CUI [3,2])
C0010674 (UMLS CUI [4])
C0409974 (UMLS CUI [5])
C1456587 (UMLS CUI [6])
HIV Infection | HAART
Item
patients diagnosed with hiv or initiating haart therapy before and at study cohort entry.
boolean
C0019693 (UMLS CUI [1])
C0887947 (UMLS CUI [2])
Hospitalization Pancreatitis
Item
patients hospitalized for acute pancreatitis in the 30 days before study cohort entry.
boolean
C0019993 (UMLS CUI [1,1])
C0030305 (UMLS CUI [1,2])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial